Jove
Visualize
Contact Us

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Molecular Cross-talk Via Extracellular Vesicles For The Characterization Of Young Subjects With Type 1 Diabetes Unravels New Potential Markers Of Insulin Resistance And Double Diabetes.
  1. Home
  2. Molecular Cross-talk Via Extracellular Vesicles For The Characterization Of Young Subjects With Type 1 Diabetes Unravels New Potential Markers Of Insulin Resistance And Double Diabetes.

Related Experiment Video

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.0K

Molecular cross-talk via extracellular vesicles for the characterization of young subjects with type 1 diabetes

Maria Concetta Cufaro1,2, Ilaria Cicalini1, Paola Irma Guidone3

  • 1Department of Innovative Technologies in Medicine and Dentistry, G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy.

Diabetology & Metabolic Syndrome
|December 10, 2025

View abstract on PubMed

Summary
This summary is machine-generated.
Keywords:
AcylcarnitinesDouble diabetesExtracellular vesiclesFACS-ProteomicsInsulin resistance

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K
Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
07:45

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

103

Related Experiment Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.0K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K
Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
07:45

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

103

This study reveals a distinct metabolic profile in children with type 1 diabetes and insulin resistance, identifying specific extracellular vesicles and acylcarnitines as key indicators. These findings offer a clearer metabolic fingerprint for managing pediatric diabetes complications.

Area of Science:

  • Metabolomics
  • Proteomics
  • Extracellular Vesicle Biology

Background:

  • Insulin resistance (IR) assessment in pediatric type 1 diabetes (T1DM) using eGDR is inconsistent.
  • Children with T1DM and IR (
  • double diabetes
  • ) require a clearer metabolic understanding.
  • Extracellular vesicles (EVs) play a role in metabolic cross-talk.

Purpose of the Study:

  • To define the metabolic
  • fingerprint
  • in pediatric T1DM with IR.
  • To investigate the role of EVs in the metabolic alterations of T1DM with IR.
  • To identify specific biomarkers for distinguishing T1DM with and without IR.

Main Methods:

  • Paediatric T1DM patients classified as insulin-resistant (T1DM+, eGDR < 8 mg/Kg/min) or non-insulin-resistant (T1DM-, eGDR > 8 mg/Kg/min).
  • Analysis of amino acids (AAs) and acylcarnitines (ACs) in dried blood spots (DBS) using FIA-MS/MS.
  • EV isolation via flow cytometry and subsequent shotgun proteomics analysis by LC-MS/MS.
  • Main Results:

    • T1DM+ EVs contained proteins linked to suppressed fatty acid metabolism and STAT3 inhibition, suggesting potential liver damage.
    • Elevated levels of oleoylcarnitine (C18:1), linoleoylcarnitine (C18:2), and myristoylcarnitine (C14) were observed in T1DM+ patients.
    • A statistical model identified palmitoleoylcarnitine (C16:1) and C18:1 as key distinguishing metabolites, with C16:1 significantly correlating with eGDR.

    Conclusions:

    • A combined
    • omics
    • approach elucidated a novel metabolic profile in pediatric T1DM with obesity and IR.
    • EVs are identified as organized and functionalized carriers of metabolic information.
    • This study provides a refined understanding of metabolic complications in a complex pediatric diabetes population.